Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Maintains Buy on Macrogenics, Raises Price Target to $16

Citigroup analyst Yigal Nochomovitz maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $13 to $16.
byBenzinga Newsdesk
August 29, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Citigroup analyst Yigal Nochomovitz maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $13 to $16.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Uber, Honeywell And Other Industrials Stocks From Wall Street’s Most Accurate Analysts

By Avi Kapoor
December 29, 9:52 AM
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst's opinion to trust.

CAT